Phlow’s capital raise announcement came a day after Gov. Glenn Youngkin and British pharmaceutical firm AstraZeneca publicly ...

The arrangement will allow medicines to be built inside the United States from start to finish, Phlow's CEO said.

Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), and Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine ...

The new funding helps Phlow accelerate its mission to help make ingredients for medicines either considered in short supply ...

Richmond-based pharmaceutical manufacturing company Phlow announced Tuesday that it had secured $37 million in a capital raise.

RICHMOND, Va., May 19, 2020 /PRNewswire/ -- Phlow, a U.S.-based, public benefit drug manufacturing corporation, has received federal government funding of $354 million for advanced manufacturing ...

Earlier this week, the U.S. government awarded a $354 million contract to a new public benefit company called Phlow to make generics that are in short supply during the pandemic. The move, which ...

Phlow is in a partnership with Utah-based pharmaceutical manufacturer Civica Inc., which plans to invest $124.5 million to establish its North American manufacturing headquarters operation in ...

“Phlow has embarked on a bold mission to provide access to affordable, high-quality essential medicines for every American,” said Eric Edwards, M.D., Ph.D., co-founder, president and CEO of Phlow.